


Bridging Health Disparities: Repatha's Multicultural Campaign for the Hispanic Community
Role: Creative Director / Art
Problem: Addressing the high LDL cholesterol incidences in the Hispanic Community
Repatha (evolocumab) is a PCSK9 inhibitor medication used to lower LDL cholesterol levels in patients with high cholesterol or familial hypercholesterolemia. The pharmaceutical company developing Repatha recognized the importance of addressing health disparities within the Hispanic community. To ensure equal access to effective cholesterol management, they launched a comprehensive multicultural marketing campaign. This case study examines the insights, strategies, and outcomes of the campaign.
​
Insights:
-
Health Disparities: Hispanics face barriers to healthcare and cholesterol management.
-
Cultural Awareness: Understanding cultural preferences improves patient communication.
-
Language Access: Providing information in Spanish enhances patient understanding.
-
Awareness and Education: Raising awareness about cholesterol management is vital.
-
Affordability and Insurance Coverage: Ensuring access to Repatha for uninsured Hispanics.
-
Clinical Trials and Research: Encouraging diverse representation in trials for better understanding.
-
Physician-Patient Communication: Improving communication for treatment adherence.
Approach:
-
Multicultural Website: Launched a Spanish website for the Hispanic community.
-
Banner Ads and Social Media: Used culturally relevant ads to drive traffic to the website.
-
Community Outreach Programs: Conducted educational programs in Hispanic neighborhoods.
-
Bilingual Patient Support: Provided assistance with insurance and financial resources.
-
Collaboration with Healthcare Organizations: Partnered with Hispanic healthcare groups.
Outcome:
-
Increased Awareness and Understanding: Raised awareness about cholesterol management.
-
Improved Access to Repatha: Enhanced access for uninsured Hispanics.
-
Diverse Clinical Trial Participation: Encouraged diverse representation in research.
-
Enhanced Physician-Patient Communication: Improved communication for better adherence.

















